On January 17, 2024, Epicore Biosystems, Inc. closed the transaction. The transaction included participation from new investors, Pegasus Tech Ventures, Inc. and Denka Company Limited. The company has raised $1,539,999 pursuant to exemption provided under Regulation D from 2 investors